Joseph Hulihan
2021
In 2021, Joseph Hulihan earned a total compensation of $1.9M as Chief Medical Officer at MARINUS PHARMACEUTICALS, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $153,000 |
|---|---|
| Option Awards | $1,238,550 |
| Salary | $450,000 |
| Other | $18,912 |
| Total | $1,860,462 |
Hulihan received $1.2M in option awards, accounting for 67% of the total pay in 2021.
Hulihan also received $153K in non-equity incentive plan, $450K in salary and $18.9K in other compensation.
Rankings
In 2021, Joseph Hulihan's compensation ranked 6,324th out of 12,415 executives tracked by ExecPay. In other words, Hulihan earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,324 out of 12,415 | 49th |
Division Manufacturing | 2,692 out of 5,505 | 51st |
Major group Chemicals And Allied Products | 1,182 out of 2,375 | 50th |
Industry group Drugs | 1,052 out of 2,096 | 50th |
Industry Pharmaceutical Preparations | 762 out of 1,546 | 51st |
Source: SEC filing on April 11, 2022.
Hulihan's colleagues
We found two more compensation records of executives who worked with Joseph Hulihan at MARINUS PHARMACEUTICALS in 2021.